Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.48 |
| ▸ | MAPT | P10636 | 8/20 | 0.48 |
| ▸ | HTT | P42858 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | G6PD | P11413 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.45 |
| ▸ | MAOB | P27338 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18735896 | 0.87 | CDK2 (0.74) | CDK2KDM4EMAPTHTTLMNA | |
| SCHEMBL22749158 | 0.75 | CDK2 (0.74) | CDK2KDM4EMAPTHTTG6PD | |
| SCHEMBL22103735 | 0.73 | MAPT (0.61) | CDK2KDM4EMAPTHTTLMNA | |
| SCHEMBL9833860 | 0.72 | CDK2 (0.70) | CDK2KDM4EMAPTHTTLMNA | |
| SCHEMBL9833864 | 0.72 | CDK2 (0.70) | CDK2KDM4EMAPTHTTLMNA | |
| SCHEMBL5406815 | 0.72 | KDM4E (0.65) | KDM4EMAPTHTTLMNAMAOA | |
| SCHEMBL5406816 | 0.72 | KDM4E (0.65) | KDM4EMAPTHTTLMNAMAOA | |
| SCHEMBL14431310 | 0.71 | KDM4E (0.48) | CDK2KDM4EMAPTHTTLMNA | |
| SCHEMBL18688530 | 0.71 | KMT2A (0.49) | CDK2KDM4EMAPTLMNAALDH1A1 | |
| SCHEMBL22624828 | 0.70 | CDK2 (0.56) | CDK2KDM4EMAPTHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10471028-B2 | Small molecule efflux pump inhibitors | UNIVERSITY OF ROCHESTER (US) | 2019-11-12 | — | — | US | disclosed |
| US-20170100414-A1 | SMALL MOLECULE EFFLUX PUMP INHIBITORS | UNIVERSITY OF ROCHESTER (US) | 2017-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10471028-B2 | Small molecule efflux pump inhibitors | ABCB11, ABCB1, ABCC1 | CDK2 4648/4885KDM4E 3300/4885MAPT 3758/4885 |
| US-20170100414-A1 | SMALL MOLECULE EFFLUX PUMP INHIBITORS | ABCB11, ABCB1, ABCC1 | CDK2 4648/4885KDM4E 3300/4885MAPT 3758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.